AHPI stock: buy or sell?

AHPI stock price: $9.94 -1.68% At close on May 26th, 2020

Updated on:
May 26th, 2020

0

After sliding a chilling -10.88% on Friday, Allied Healthcare Products closed today at $9.94 and fell a fatal -1.68%. Tuesday was the fifth red session in a row, sliding in full a -23.25%. On May 14th AHPI rocketed an extraordinary 8.06%.

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide.

Should I buy AHPI stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading strategy that matches with your character as inversor. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Allied Healthcare Products stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean AHPI will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Allied Healthcare Products stock a buy?

Financial institutions and banks publish stock ratings everyday. Unfortunately, we couldn't detect any rating for AHPI stock for the last month.

AHPI stock analysis

Daily outlook

After sliding a chilling -10.88% on Friday, Allied Healthcare Products closed today at $9.94 and fell a fatal -1.68%.

On February, AHPI hit new all time highs, pushing higher previous ATH of $38.32 recorded . New ATHs are usual entry points for many trading setups as there aren't higher resistences. After sliding a chilling -10.88% on Friday, Allied Healthcare Products closed today at $9.94 and fell a fatal -1.68%. Since SMA100d and SMA200d crossed up on February, AHPI price slid a -35.95%. Since last January when AHPI stock price broke up the SMA200d line, it gained $8.44 (562.67%).

AHPI stock chart (daily)

Weekly outlook

After sliding a dreadful -25.91% in a week last week, Allied Healthcare Products closed this week at $9.94 and decreased an ugly -1.68%. By mid May AHPI rocketed a dazzling 9.74% in just one week.

Not so far away is the last price record Allied Healthcare Products marked late February, but since then it dropped a 77.91%. Having descending tops is not good news for investors in AHPI. Although it's only a warning signal, traders should be on alert during next weeks to identify possible new signals. It's important AHPI stock price keeps the level, and maybe bounce up from there forming a double bottom configuration. Late February, SMA20w and SMA40w crossed up triggering a rise of 304.07%. Since price and SMA40w lines crossed up by mid January, AHPI climbed $8.60 (641.79%).

AHPI stock chart (weekly)

AHPI stock price history

AHPI stock went public on January 14th, 1992 with a price of $16.801. Since then, AHPI stock lost a -40.80%, with a yearly average of -1.50%.

1: Adjusted price after possible price splits or reverse-splits.

AHPI stock historical price chart

AHPI stock reached all-time highs on February with a price of $45.00.

AHPI stock price target

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' AHPI stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not detected any price forecast for Allied Healthcare Products stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

After posting its last earnings report , Allied Healthcare Products . As soon as we get its posted EPS from the earnings report, we will extend this review.
AHPI earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.1n/a
2017-Q2-n/a-0.12n/a
2017-Q3-n/a-0.19n/a
2017-Q42018-04-03n/an/an/a
2018-Q12018-05-15n/a-0.22n/a
2018-Q22018-09-28n/a-0.04n/a
2018-Q32018-11-14n/a-0.31n/a
2018-Q42019-04-03n/an/an/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In 2018, Allied Healthcare Products annual turnover remained steady a tiny 0.74% to $33.76 M USD from $33.51 marked in 2017. When comparing 2018 vs 2017, likewise, profit margin (that is, the net income divided by revenues) stayed constant a -0.26% to -6.49%.

Allied Healthcare Products presents anual results in June, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Allied Healthcare Products TTM sales up to December 2018 were $32.52 and income $-3.06 million dollars. If we compare this TTM figures with the last reported annuality, we can review Allied Healthcare Products business evolution since June 2018: Annual revenues up to December, compared to lastest yearly report, depreciated an unpleasant -3.67%. Regarding profit margin, Allied Healthcare Products declined -2.91% to -6.49%

AHPI annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$39 M-$-1.26 M-3.3%-
2014$36 M-5.65%$-2.81 M-7.7%123.02%
2015$35 M-2.50%$-1.78 M-5.0%-36.75%
2016$36 M1.38%$-2.30 M-6.4%29.68%
2017$34 M-6.79%$-2.09 M-6.2%-9.38%
2018$34 M0.74%$-2.19 M-6.5%4.96%
TTM $33 M-3.67%$-3.06 M-9.4%39.51%

Quarterly financial results

Allied Healthcare Products reported $8.11 million in revenues for 2018-Q4, a 11.53% up compared to previous quarter. Reported quarter earnings marked $-0.78 million with a profit margin of -9.61%. Profit margin jumped a 7.37% compared to previous quarter when profit margin was -16.98%. When comparing turnover to same quarter last year, Allied Healthcare Products sales marked a rough correction and dropped a -7.01%.
AHPI quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q1$9 M-$-0.40 M-4.7%-
2017-Q2$8 M-4.20%$-0.49 M-6.0%22.60%
2017-Q3$8 M-3.93%$-0.77 M-9.7%55.19%
2017-Q4$9 M10.41%$-0.38 M-4.4%-50.38%
2018-Q1$8 M-2.89%$-0.90 M-10.6%136.68%
2018-Q2$9 M2.49%$-0.14 M-1.7%-84.11%
2018-Q3$7 M-16.23%$-1.23 M-17.0%762.11%
2018-Q4$8 M11.53%$-0.78 M-9.6%-36.87%

Allied Healthcare Products ownership

Reviewing Allied Healthcare Products ownership structure gives valuable information about the company and its governance (insider ownership) or the amount of investors that are on the short side.

Allied Healthcare Products shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 62.88% of all shares.

In case of Allied Healthcare Products stock, 11.18% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for AHPI stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Allied Healthcare Products:

AHPI
Market cap$39.9 M
Total shares4.0 M
Float shares3.1 M
  - Institutional holdings (%)11.2%
  - Insider holdings (%)62.9%
Shares in short selling0.0%

AHPI summary

Tuesday, May 26th, 2020
Open$10.21
Close$9.94
Day range$9.58 - $10.24
Previous close$10.11
Session gain-1.68%
Average true range$1.52
50d mov avg$14.30
100d mov avg$9.90
200d mov avg$5.65
Daily patternlt06c
Weekly pattern lt01a

Allied Healthcare Products performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Allied Healthcare Products, the comparison is made against .
Stock3m6m12m
AHPIAllied Healthcare...-58.58%894.00%521.25%

Allied Healthcare Products competitors

Unfortunately, we could not find any public company that could be defined as Allied Healthcare Products competitor. This doesn't mean Allied Healthcare Products does not have any competitor in the market, it's just we could not detected it.